Search
Close this search box.

eSudoe
2021
2027

RePo-SUDOE

Drug Repurposing for Effective and Accelerated Drug Development in the SUDOE Space

Resumen

Can the SUDOE space be recognised as being of excellence in the area of “drug repurposing”? Currently, the development of new drugs has high failure rates, costs and delinquency. This justifies the emergence of drug repurposing, allowing new therapeutic indications for drugs already available on the market, with benefit to the pharmaceutical industry, society and patients. The RePo-SUDOE project seeks to develop and disseminate technologies for drug repurposing with the aim of increasing the competitiveness of the SUDOE space in this area of R & D, promoting the biopharmaceutical industry and capturing trained human resources. This objective will be achieved through 3 specific objectives: 1) Promote scientific knowledge and disseminate drug repurposing technology together with public and private actors, raising the groups and R & D centers of the SUDOE space to the level of European excellence in this area of R & D; 2) Enhance multidisciplinary collaboration and identify opportunities and innovative initiatives in the SUDOE territory for drug repurposing, through the implementation of a transnational network. A database with information on therapeutic targets and drugs with biological activity will be created. As the main case study, drug repurposing methodologies will be developed for the treatment of cancer; 3) Create a three-dimensional (3D) display room prototype of biological systems, which will function as a pilot in the SUDOE territory. It will be a space with virtual reality technology and augmented reality that allows the 3D visualisation of therapeutic objectives and their interaction with drugs, in an interactive and pedagogical way, dedicated to young students and researchers from STEAM areas. This project brings together, for the first time, partners from different SUDOE regions and different areas of the drug development value chain, in a common drug repurposing project. The RePo-SUDOE will put at the service of the scientific information society of easy consultation and open access, and decisive visualisation technologies for the affirmation of the area of drug repurposing in the SUDOE space.

Descripción

Can the SUDOE space be recognised as being of excellence in the area of “drug repurposing”? Currently, the development of new drugs has high failure rates, costs and delinquency. This justifies the emergence of drug repurposing, allowing new therapeutic indications for drugs already available on the market, with benefit to the pharmaceutical industry, society and patients. The RePo-SUDOE project seeks to develop and disseminate technologies for drug repurposing with the aim of increasing the competitiveness of the SUDOE space in this area of R & D, promoting the biopharmaceutical industry and capturing trained human resources. This objective will be achieved through 3 specific objectives: 1) Promote scientific knowledge and disseminate drug repurposing technology together with public and private actors, raising the groups and R & D centers of the SUDOE space to the level of European excellence in this area of R & D; 2) Enhance multidisciplinary collaboration and identify opportunities and innovative initiatives in the SUDOE territory for drug repurposing, through the implementation of a transnational network. A database with information on therapeutic targets and drugs with biological activity will be created. As the main case study, drug repurposing methodologies will be developed for the treatment of cancer; 3) Create a three-dimensional (3D) display room prototype of biological systems, which will function as a pilot in the SUDOE territory. It will be a space with virtual reality technology and augmented reality that allows the 3D visualisation of therapeutic objectives and their interaction with drugs, in an interactive and pedagogical way, dedicated to young students and researchers from STEAM areas. This project brings together, for the first time, partners from different SUDOE regions and different areas of the drug development value chain, in a common drug repurposing project. The RePo-SUDOE will put at the service of the scientific information society of easy consultation and open access, and decisive visualisation technologies for the affirmation of the area of drug repurposing in the SUDOE space.

Periodo de programación:2021-2027
Fecha de inicio:01/01/2024
Fecha fin:31/12/2026
Estado: On going
Convocatoria: 1st call
Prioridad:2 - Promoting social cohesion and territorial and demographic balance in Sudoe through innovation and the transformation of productive sectors
Objetivo específico:SO 1.1 (...) Research / Innovation
Coste subvencionable: 1.817.387,21 euros
Ayuda FEDER: 1.363.040,40 euros

Beneficiarios

Principal Beneficiary: Instituto Politécnico da Guarda, Escola Superior de Saúde, Unidade Técnico-Científica - Tecnologias da Saúde

Nombre del beneficiario: Instituto Politécnico da Guarda, Escola Superior de Saúde, Unidade Técnico-Científica - Tecnologias da Saúde

Región: Portugal,Centro,Guarda

Persona de contacto: Cristina Castro

Email: [email protected]

This beneficiary does not have a website

2 - Universidade da Coruña, Vicerrectoría de Investigación y Transferencia, Redes de Neuronas Artificiais e Sistemas Adaptativos -Informática Médica e Diagnóstico Radiolóxico

Nombre del beneficiario: Universidade da Coruña, Vicerrectoría de Investigación y Transferencia, Redes de Neuronas Artificiais e Sistemas Adaptativos -Informática Médica e Diagnóstico Radiolóxico

Región: España,Galicia,A Coruña

Persona de contacto: Carlos Fernández Lozano

Email: [email protected]

This beneficiary does not have a website

3 - Universidade de Santiago de Compostela, Centro Singular de Investigación en Química Biológica y Materiales Moleculares

Nombre del beneficiario: Universidade de Santiago de Compostela, Centro Singular de Investigación en Química Biológica y Materiales Moleculares

Región: España,Galicia,Santiago de Compostela

Persona de contacto: Rebeca Garcia Fandiño

Email: [email protected]

This beneficiary does not have a website

4 - MD.USE Innovations S.L., MD.USE Innovations S.L., MD.USE Innovations S.L.

Nombre del beneficiario: MD.USE Innovations S.L., MD.USE Innovations S.L., MD.USE Innovations S.L.

Región: España,Galicia,Santiago de Compostela

Persona de contacto: Ángel Piñero Guillén

Email: [email protected]

This beneficiary does not have a website

5 - SPSP - Sociedade Portuguesa de Saúde Pública

Nombre del beneficiario: SPSP - Sociedade Portuguesa de Saúde Pública

Región: Portugal,Área Metropolitana de Lisboa,Lisboa

Persona de contacto: Maria Rita Pessoa

Email: [email protected]

This beneficiary does not have a website

6 - Centre National de la Recherche Scientifique - Délégation Aquitaine, Chimie et Biologie des Membranes et des Nano-objets - CBMN

Nombre del beneficiario: Centre National de la Recherche Scientifique - Délégation Aquitaine, Chimie et Biologie des Membranes et des Nano-objets - CBMN

Región: France,Aquitaine (Nouvelle Aquitaine),Talence

Persona de contacto: Birgit HABENSTEIN

Email: [email protected]

This beneficiary does not have a website

7 - Asociacion Cluster Saúde de Galicia

Nombre del beneficiario: Asociacion Cluster Saúde de Galicia

Región: España,Galicia,Santiago de Compostela

Persona de contacto: Gisela Garcia-Alvarez

Email: [email protected]

This beneficiary does not have a website